Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Assisted Reproduction and Genetics
Published in: Journal of Assisted Reproduction and Genetics 10/2019

01-10-2019 | Fertility | Assisted Reproduction Technologies

Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations

Authors: Kaitlyn Wald, Joseph Letourneau, Rachel Eshima-McKay, John Monks, Evelyn Mok-Lin, Marcelle Cedars, Mitchell Rosen

Published in: Journal of Assisted Reproduction and Genetics | Issue 10/2019

Login to get access

Excerpt

Over the past decades, assisted reproductive care has become increasingly safe and more widely applied. Egg retrieval has become an outpatient procedure, with ultrasound guidance, and stimulations have increasingly become less aggressive and safer with more individualization and safer trigger options. With this improvement in care, these treatments are considered low risk and applied more widely, including fertility preservation for elective reasons (so-called social egg freezing). However, it is incumbent upon providers to realize the application of even “simple” treatments, in a high-risk population, may have serious consequences. …
Literature
1.
2.
3.
Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118(6):1710–7.PubMedCrossRef
4.
Ethics Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o., Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril, 2018. 110(3): p. 380–386.
5.
Anazodo A, Ataman-Millhouse L, Jayasinghe Y, Woodruff TK. Oncofertility-an emerging discipline rather than a special consideration. Pediatr Blood Cancer. 2018;65(11):e27297.PubMedPubMedCentralCrossRef
6.
7.
Letourneau JM, Sinha N, Wald K, Harris E, Quinn M, Imbar T, et al. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod. 2017;32(10):2123–9.PubMedCrossRef
8.
Pecker LH, Maher JY, Law JY, Beach MC, Lanzkron S, Christianson MS. Risks associated with fertility preservation for women with sickle cell anemia. Fertil Steril. 2018;110(4):720–31.PubMedCrossRef
9.
Ferschl MB, Tung A, Sweitzer BJ, Huo D, Glick DB. Preoperative clinic visits reduce operating room cancellations and delays. Anesthesiology. 2005;103(4):855–9.PubMedCrossRef
10.
Reilly DF, McNeely MJ, Doerner D, Greenberg DL, Staiger TO, Geist MJ, et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med. 1999;159(18):2185–92.PubMedCrossRef
11.
Subramani Y, Wong J, Nagappa M, Chung F. The benefits of perioperative screening for sleep apnea in surgical patients. Sleep Med Clin. 2017;12(1):123–35.PubMedCrossRef
12.
Cartagena R. Preoperative evaluation of patients with obesity and obstructive sleep apnea. Anesthesiol Clin North Am. 2005;23(3):463–78 vi.PubMedCrossRef
13.
Subramani Y, Nagappa M, Wong J, Mubashir T, Chung F. Preoperative evaluation: estimation of pulmonary risk including obstructive sleep apnea impact. Anesthesiol Clin. 2018;36(4):523–38.PubMedCrossRef
14.
Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373(23):2258–69.PubMedCrossRef
15.
Bechard P, et al. Perioperative cardiorespiratory complications in adults with mediastinal mass: incidence and risk factors. Anesthesiology. 2004;100(4):826–34; discussion 5A.PubMedCrossRef
16.
Grocott HP, Gulati H, Srinathan S, Mackensen GB. Anesthesia and the patient with pericardial disease. Can J Anaesth. 2011;58(10):952–66.PubMedCrossRef
17.
Goh MH, Liu XY, Goh YS. Anterior mediastinal masses: an anaesthetic challenge. Anaesthesia. 1999;54(7):670–4.PubMedCrossRef
18.
19.
20.
Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical practice guidelines from the AABB red blood cell transfusion thresholds and storage. Jama-J Am Med Assoc. 2016;316(19):2025–35.CrossRef
21.
Ye R, et al. Timing embryo preservation for a patient with high-risk newly diagnosed acute myeloid leukemia. Case Rep Hematol. 2018;2018:9807047.PubMedPubMedCentral
22.
Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001;16(4):632–7.PubMedCrossRef
23.
Brunicardi FC, et al. Schwartz’s principles of surgery. Tenth ed. New York: McGraw-Hill Education; 2014.
24.
25.
Howard SC, Trifilio S, Gregory TK, Baxter N, McBride A. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Ann Hematol. 2016;95(4):563–73.PubMedCrossRef
26.
Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C, et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arterioscler Thromb Vasc Biol. 2009;29(12):2176–81.PubMedCrossRef
27.
Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404–13.PubMedCrossRef
28.
Mahajan A, et al. The epidemiology of cancer-associated venous thromboembolism: an update. Semin Thromb Hemost. 2019.
29.
Chan WS. The ‘ART’ of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21(3):207–18.PubMedCrossRef
30.
Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95–100.PubMedCrossRef
31.
Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):92–128.PubMedPubMedCentralCrossRef
32.
Gurunath S, Vinekar S, Biliangady R. Assisted reproductive techniques in a patient with history of venous thromboembolism: a case report and review of literature. J Hum Reprod Sci. 2018;11(2):193–7.PubMedPubMedCentralCrossRef
33.
Somigliana E, Peccatori FA, Filippi F, Martinelli F, Raspagliesi F, Martinelli I. Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation. Hum Reprod Update. 2014;20(6):944–51.PubMedCrossRef
34.
Practice Committee of the American Society for Reproductive Medicine. Electronic address, A.a.o. and M. Practice Committee of the American Society for reproductive, prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril, 2016. 106(7): p. 1634–1647.
35.
Goldsman MP, Pedram A, Dominguez CE, Ciuffardi I, Levin E, Asch RH. Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil Steril. 1995;63(2):268–72.PubMedCrossRef
36.
Namavar Jahromi BM, et al. Ovarian hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management. Iran J Med Sci. 2018;43(3):248–60.
37.
38.
Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Hum Reprod. 2016;31(6):1253–64.PubMedCrossRef
39.
Youssef MA, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev. (2011, 1):CD008046.
40.
Anaya Y, Mata DA, Letourneau J, Cakmak H, Cedars MI, Rosen MP. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols (vol 35, pg 297, 2017). J Assist Reprod Genet. 2018;35(2):309–9.
Metadata
Title
Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations
Authors
Kaitlyn Wald
Joseph Letourneau
Rachel Eshima-McKay
John Monks
Evelyn Mok-Lin
Marcelle Cedars
Mitchell Rosen
Publication date
01-10-2019
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 10/2019
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-019-01556-0

Other articles of this Issue 10/2019

Journal of Assisted Reproduction and Genetics 10/2019 Go to the issue

Assisted Reproduction Technologies

Risk of adverse perinatal outcomes after oocyte donation: a systematic review and meta-analysis

Gamete Biology

Biphasic in vitro maturation (CAPA-IVM) specifically improves the developmental capacity of oocytes from small antral follicles

Commentary

Rediscovering FISH in the midst of a sperm chromatin conundrum

Assisted Reproduction Technologies

When next-generation sequencing-based preimplantation genetic testing for aneuploidy (PGT-A) yields an inconclusive report: diagnostic results and clinical outcomes after re biopsy

Assisted Reproduction Technologies

A treatment approach for couples with disrupted sperm DNA integrity and recurrent ART failure

Assisted Reproduction Technologies

Effect of the vaginal microbiome on the pregnancy rate in women receiving assisted reproductive treatment